跳至主要内容
临床试验/NCT03753048
NCT03753048Unknown不适用

Comparison of Total Arterial Revascularization of Y-Graft Versus In-Situ Configuration Using Bilateral Internal Thoracic Arteries

Meshalkin Research Institute of Pathology of Circulation2 个研究点 分布在 1 个国家目标入组 880 人开始时间: 2018年3月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
880
试验地点
2
主要终点
Freedom from MACCE

研究概览

简要总结

Total arterial revascularisation with in-situ confihuration of BITA is superior than y-graft in patients underwent CABG.

详细描述

The main hypothesis of the trial is that in-situ configuration of bilateral internal thoracic arteries is superior than Y-graft configuration for MACCE (mortality, myocardial infarction, repeat revascularization, stroke) during mid-term follow-up in patients with CAD who is shedueled for CABG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Coronary Artery Disease
  • Stable angina
  • The need for revascularization of anterior descending and obtuse margin arteries accoring to the 2018 ESC/EACTS Guidelines on myocardial revascularization
  • Informed Consent Form

排除标准

  • The diameter of the target arteries is less than 1 mm
  • Stenosis of the subclavian arteries more than 60%
  • STEMI less than 3 month
  • Previous cardiac surgery
  • COPD with FEV1 <60%
  • Concomitant pathology that requires simultaneous surgical treatment
  • Cancer with life expectancy less than 5 years

研究组 & 干预措施

Y-Graft

Active Comparator

The group includes patients who underwent CABG in Y-Graft Configuration.

干预措施: Y-Graft (Procedure)

In-Situ

Active Comparator

The group includes patients who underwent CABG in In-Situ Configuration.

干预措施: In-Situ (Procedure)

结局指标

主要结局

Freedom from MACCE

时间窗: 5 years

Composite MACCE (mortality, myocardial infarction, repeated revascularization, stroke)

次要结局

  • Treadmill stress test(5 years)
  • Graft patency(5 years)
  • Quality of life (SF-36)(5 years)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Principal Investigator
主要研究者

Dmitry Sirota

Head of the surgery of aorta and coronary arteries department

Meshalkin Research Institute of Pathology of Circulation

研究点 (2)

Loading locations...

相似试验

Total Arterial Revascularization (TAR) | 临床试验